WO2017185758A1 - Primer, probe, kit, and method for microchimerism assay and individual recognition - Google Patents

Primer, probe, kit, and method for microchimerism assay and individual recognition Download PDF

Info

Publication number
WO2017185758A1
WO2017185758A1 PCT/CN2016/109157 CN2016109157W WO2017185758A1 WO 2017185758 A1 WO2017185758 A1 WO 2017185758A1 CN 2016109157 W CN2016109157 W CN 2016109157W WO 2017185758 A1 WO2017185758 A1 WO 2017185758A1
Authority
WO
WIPO (PCT)
Prior art keywords
seq
primer
probe
primers
group
Prior art date
Application number
PCT/CN2016/109157
Other languages
French (fr)
Chinese (zh)
Inventor
郑仲征
杜金伟
Original Assignee
上海荻硕贝肯生物科技有限公司
上海荻硕贝肯医学检验所有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 上海荻硕贝肯生物科技有限公司, 上海荻硕贝肯医学检验所有限公司 filed Critical 上海荻硕贝肯生物科技有限公司
Publication of WO2017185758A1 publication Critical patent/WO2017185758A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Definitions

  • the present invention relates to the field of genetic engineering technology, and in particular to primers, probes, kits and methods for microchimeric detection and individual recognition.
  • a gene is a generic term for a specific nucleotide sequence with a genetic effect on a DNA (deoxyribonucleic acid) molecule, and is a fragment of a DNA molecule with a genetic effect.
  • Genes can not only transmit genetic information to the next generation through replication, but also enable the expression of genetic information. This genetic information is contained in all human tissues or organs such as human bones, hair, and blood. Genetic testing to identify different individuals through differences in human genomic polymorphism sites has been widely used in forensic and clinical trials.
  • STR Short Tandem Repeats
  • a chimera refers to a cell mosaic phenomenon in which different genetic traits exist in the same individual, that is, a state in which two or more sets of chromosomes are contained.
  • microchimerism refers to a phenomenon in which the cellular components of different individual sources are less than 1%. Micro-chimeric detection requires a more sensitive detection method. Therefore, the STR cannot perform micro-chimeric analysis.
  • SNP Single Nucleotide Polymorphism
  • SNP site amplification product can be controlled below 200 bp, which is beneficial to degradation of samples.
  • the difference between SNP alleles is only one base, so it is difficult to design a highly sensitive detection scheme with a detection sensitivity of only 1%, which is still not suitable for micro-chimeric detection.
  • the SNP quantitative method is complicated, the experimental instrument is expensive, the use cost is high, the operation is cumbersome, the flux is small, and it is not suitable for promotion in a conventional forensic laboratory.
  • Insertion or Deletion Polymorphisms is formed by inserting or deleting DNA fragments of different types and sizes (4-22 bp) in the genome.
  • Polymorphic genetic markers are widely used in forensic evidence identification, paternity testing and other medical tests.
  • the InDel marker has the following characteristics: (1) abundant in the human genome, second only to the SNP; (2) natural mutation rate similar to the SNP ( ⁇ 2.3 ⁇ 10 -9 ) (3) The InDel amplified fragment is shorter (less than 160bp), which is more suitable for detecting highly degraded and low-copy DNA templates, increasing the success rate of DNA degradation sample typing; (4) There are significant populations in the InDel locus.
  • InDel detection by fluorescence PCR amplification technology the technical platform is generally applicable;
  • commercially available kits for micro-chimeric detection and individual recognition based on InDel genetic markers are rare, and only the Dutch Investigator DIP kit is a relatively mature commercial product.
  • the Investigator DIP kit is not particularly applicable to Asian populations due to differences in population and ethnicity of genetic markers. Therefore, it is necessary to develop a set of InDel genetic marker kits for micro-chimeric detection and individual identification for the Asian population.
  • the present invention is directed to the above-mentioned drawbacks existing in the prior art, based on the latest InDel site database, and based on the Asian population, redesigned primers and probes for microchimerism detection and individual recognition, and detection methods.
  • the detection method of the invention has strong polymorphism, good specificity, high sensitivity and is simple and quick.
  • one aspect of the invention provides a primer and probe combination for microchimeric detection and individual recognition consisting of the primers and probes set forth in SEQ ID NO. 1-75.
  • the primer and probe combination further consists of a set 1-15 set of primers and probes, wherein the first set consists of the primers set forth in SEQ ID NO. 1-4 and SEQ ID NO.
  • the probe composition shown the second group consists of the primers shown in SEQ ID NO. 6-9 and SEQ ID NO.
  • the probe composition is shown, the third group consists of the primers shown in SEQ ID NO. 11-14 and the probes shown in SEQ ID NO. 15, and the fourth group consists of the primers shown in SEQ ID NO. 16-19.
  • probes of SEQ ID NO. 20, group 5 consists of the primers shown in SEQ ID NO. 21-24 and the probes shown in SEQ ID NO.
  • the sixth group consists of SEQ ID NO.
  • the probe composition shown in .55, the 12th group consists of the primers shown in SEQ ID NO. 56-59 and the probes shown in SEQ ID NO. 60, and the 13th group is represented by SEQ ID NO. 61-64.
  • the primer is composed of the probe shown in SEQ ID NO. 65, and the 14th group is the primer shown in SEQ ID NO. 66-69 and SEQ ID NO.
  • the probe composition shown by 0, the 15th group consists of the primer shown in SEQ ID NO. 71-74 and the probe shown in SEQ ID NO.
  • the invention is based on the latest InDel locus database, and based on the Asian population, 15 InDel loci for high individual recognition rate of Asian population are selected, which are: N1-1 (rs2308010), N1-2 (rs34855933). , N1-3 (rs4646006), N2-1 (rs3042783), N5-1 (rs1610937), N5-4 (rs1610932), N7-1 (rs16458), N9-1 (rs2308112), N11-1 (rs2307696), N11-2 (rs140790), N13-1 (rs3038530), N13-2 (rs3049448), N14-1 (rs56024302), N16-2 (rs2067204), and N21-1 (rs16663), the rs number in parentheses indicates the bit Point the number in the dbSNP database.
  • the present invention further designs, for each of the above InDel sites, a common upstream primer (F), a downstream primer (R), an insertion specific primer F (+), and a deletion specific primer F (-), wherein the amplified fragment Amplified Fragment Length (AFL) is the length of the amplified fragment obtained by pairing the primer with the corresponding upstream primer or downstream primer.
  • F(+) and R are used to specifically amplify the insert
  • R(-) and F Used to specifically amplify deleted fragments, F and R are used to amplify non-specific fragments (where: Represents a specific base for insertion/deletion).
  • the specific primers and probes designed by the present invention are shown in Table 1 for the 15 InDel sites of the high individual recognition rate of the above Asian population.
  • kits for microchimeric detection and individual identification the kit of which A primer and probe combination according to the invention is included.
  • the kit is stored at -20 ° C and consists of the following reagents.
  • the primer and probe combinations are separately dispensed into the corresponding numbered centrifuge tubes.
  • the concentration of each primer in the kit is 6 [mu]M and the concentration of each probe is 4 [mu]M.
  • Another aspect of the invention provides the use of the primer and probe combinations of the invention in the preparation of micro-chimeric detection and individual recognition kits.
  • a further aspect of the invention provides the use of the primers and probe combinations of the invention, or the kits of the invention for micro-chimeric detection and individual recognition.
  • a final aspect of the invention provides a method of microchimeric detection and individual identification comprising the steps of:
  • DNA extraction can be performed using the QIAamp DNA Blood Mini kit.
  • step 2 using the primer and probe combination of the present invention, or using the kit of the present invention, using the DNA obtained in step 1 as a template, performing fluorescent PCR amplification, and collecting the fluorescent signal.
  • the system for fluorescence PCR amplification is 20uL: 10uL 2 ⁇ Super Real PreMix reaction solution (Tiangen Biochemical Technology (Beijing) Co., Ltd., Item No.: FP206); 0.2uL 50 ⁇ ROX Reference Dye (Tiangen Biochemical Technology (Beijing) Co., Ltd.) , Item No.: FP206); 1uL 6uM primer F(+)/F(-); 1uL 6uM primer R; 1uL 4uM probe; 1uL 20ng/uL DNA; complement the reaction system with RNase-Free ddH 2 O.
  • the reaction conditions of the fluorescent PCR were: pre-denaturation at 95 ° C for 15 min, followed by denaturation at 95 ° C for 3 s - 60 ° C for 32 s, for a total of 40 cycles, and the fluorescence signal was collected at 60 ° C.
  • the polymorphism difference of the sample to be tested at 15 InDel sites is determined, so that the sample to be tested is subjected to micro-chimeric detection and individual recognition.
  • the Ct value of each genetic marker is used to judge the range of Ct values of positive and negative samples of each genetic marker.
  • the Ct value of positive samples falls between 24-29, the Ct value of negative samples is above 38, and the Ct values of positive and negative samples differ by more than 12 , indicating that the primers and probes have good specificity.
  • the primers and probes employed are designed for 15 InDel sites with high individual recognition rates for Asian populations.
  • each primer has a concentration of 6 [mu]M and a concentration of 4 [mu]M per probe.
  • the present invention has the following advantages as compared with the prior art.
  • the detection method of the invention adopts double fluorescent label amplification technology, which is simple and fast, and only needs one Applied Biosystems 7500 Real Time PCR System, and the result is automatically analyzed, which can ensure the accuracy of different laboratory data.
  • Figure 1 Schematic diagram of PCR amplification results for the detection of primer and probe specificity of the present invention.
  • Figure 2 A diagram of PCR amplification results for the individual recognition assay of the kit of the invention.
  • Fig. 3 is a graph showing the results of detection of the genetic marker N13-1(+) of the present invention.
  • Figure 4 Amplification plot of the standard (100%, 90%, 50%, 10%, 1%, 0.1%, 0.05%, 0.025%) of the genetic marker N13-1(+) of the present invention.
  • the InDel locus is screened using the following principles:
  • the difference in length of the InDel allele fragment is greater than 3 bp and less than 30 bp;
  • the minimum allele frequency (MAF) is between 0.30 and 0.50 (based on the East Asian population);
  • the total number of sites is not less than 30, the cumulative individual recognition rate reaches 0.9999 or more;
  • the InDel locus was initially screened, and finally 15 InDel loci were selected: N1-1 (rs2308010), N1-2 (rs34855933), N1-3 (rs4646006), N2-1 (rs3042783), N5- 1 (rs1610937), N5-4 (rs1610932), N7-1 (rs16458), N9-1 (rs2308112), N11-1 (rs2307696), N11-2 (rs140790), N13-1 (rs3038530), N13-2 (rs3049448), N14-1 (rs56024302), N16-2 (rs2067204), N21-1 (rs16663), the rs number in parentheses indicates the number of the site in the dbSNP database.
  • a total of 94 Chinese population DNA samples were randomly selected for amplification and gene sequencing. 94 healthy human genomic DNA samples were tested using the initially selected primers to assess primer amplification efficiency and gene frequency at each locus.
  • DNA extraction was performed according to the QIAamp DNA Blood Mini kit, followed by dilution with RNase-Free ddH 2 O to 20 ng/uL for use.
  • 25 uL PCR amplification system 2.5 uL 10 ⁇ buffer reaction solution; 0.75 uL 10 mM dNTP; 1 uL 5 uM primer F; 1.8 uL 5 uM primer R; 1.4 uL 5 uM primer F(+)/F(-); 2 uL DNA; uL Hot start Taq; 1 uL Mg 2+ ; 0.1 uL DMSO, supplemented with RNase-Free ddH 2 O.
  • the PCR product was electrophoresed on 2% agarose for 30 min to verify whether the specific primers were suitable. Based on the sequencing results of the first generation, the primer sequences were modified and retested for the case of electrophoresis false positives and false negatives.
  • the primers and probe sequences of the finally determined 15 InDel sites are shown in Table 1.
  • the above primers and probes were synthesized by Shanghai Yingjun Biotechnology Co., Ltd.
  • Example 1 Under the sequencing results of Example 1, five insertion homozygotes, deletion homozygotes and heterozygotes were selected for fluorescence PCR to detect the specificity of the primers and probes.
  • Adopt 20uL fluorescent PCR amplification system 10uL 2 ⁇ Super Real PreMix reaction solution (Tiangen Biochemical Technology (Beijing) Co., Ltd., Item No.: FP206); 0.2uL 50 ⁇ ROX Reference Dye (Tiangen Biochemical Technology (Beijing) Co., Ltd. , Item No.: FP206); 1uL 6uM primer F(+)/F(-); 1uL 6uM primer R; 1uL 4uM probe; 1uL 20ng/uL DNA; complement the reaction system with RNase-Free ddH 2 O.
  • the following fluorescent PCR reaction conditions were employed: pre-denaturation at 95 ° C for 15 min, followed by denaturation at 95 ° C for 3 s - 60 ° C for 32 s, for a total of 40 cycles, and the fluorescence signal was collected at 60 ° C.
  • the Ct value of each genetic marker is used to judge the range of Ct values of positive and negative samples of each genetic marker.
  • the Ct value of positive samples falls between 24-29, the Ct value of negative samples is above 38, and the Ct values of positive and negative samples differ by more than 12 , indicating that the primers and probes have good specificity.
  • the Ct values of the positive samples fall within the range 26-28 (see Figure 1a of the specification), and the negative samples (deleted homozygous) Ct
  • the values were not detectable (i.e., no fluorescence signal was detected at 40 PCR cycles, and the Ct value was greater than 40) (see Figure 1b of the specification), indicating that the primers and probes were of good specificity.
  • Example 3 Composition of the kit of the present invention
  • the InDel genetic labeling kit for microchimerism detection and individual recognition of the present invention is stored at -20 ° C and consists of the following reagents.
  • Whole blood genomic DNA extraction reagent purchased from QIAamp DNA Blood Mini kit.
  • the primer and probe combinations were separately dispensed in the corresponding numbered centrifuge tubes.
  • the concentration of each primer was 6 uM, and the concentration of each probe was 4 uM.
  • Example 4 The kit of the invention is used for the detection of individual identification
  • sample A and sample B have 14 genetic markers (N1-1(+), N1-2(-), N1-3(-), N2-1( +), N2-1(-), N5-4(+), N7-1(+), N9-1(+), N11-1(-), N11-2(-), N13-1(+ ), N13-1 (-), N14-1 (+), and N16-2 (-) have polymorphic differences. Therefore, it can be judged that the sample A and the sample B are derived from different individuals.
  • the available genetic markers For each pair of samples, select the available genetic markers (the available genetic markers should meet the following characteristics: Ct ⁇ 28 positive samples are designated as recipients, Ct>38 negative samples are designated as donors), mixed in different proportions, and different ratios are obtained.
  • the standard is tested for sensitivity and accuracy by fluorescence PCR. Meanwhile, in order to achieve a detection sensitivity of 10 -5 , the amount of the initial DNA template is at least 140 ng.
  • the fluorescent PCR reaction system and conditions were the same as in Example 2. With sample C as the recipient and sample D as the donor, the available genetic markers were selected according to the size of the Ct value (C: Ct ⁇ 28 positive samples; D: Ct > 38 negative samples).
  • sample C and sample D mix in different proportions (recipient C/donor D: 90%, 50%, 10%, 1%, 0.1%, 0.05%, 0.025%), a standard of 20 ng/uL in different ratios was obtained.
  • Figure 3 of the specification shows the detection results of the genetic marker N13-1(+).
  • the genetic marker N13-1(+) and the internal reference gene amplification curve were in good shape, the PCR product was highly specific, and there was no non-specific amplification, while the control blank group had no amplification.
  • Figure 4 is a standard amplification curve of the genetic marker N13-1(+). The figure shows that the standard amplification curve is in good shape.
  • CD as a post-transplant sample
  • the test values obtained by comparing theoretical values with fluorescent PCR can be used to determine the sensitivity and accuracy of each genetic marker.
  • the test values were 93.34% (theoretical 90%), 65.19% (theoretical 50%), 13.25% (theoretical 10%), 0.9452% (theoretical 1%), and 0.1053% (theoretical). 0.1%), 0.0598% (theoretical 0.05%) and 0.0282% (theoretical 0.025%), indicating that the primers and probes have good test accuracy, and the sensitivity can reach about 0.025%.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A primer and probe combination used for a microchimerism assay and individual recognition, a kit comprising the primer and probe combination, and a method for implementing, by using the primer and probe combination or the kit, a microchimerism assay and individual recognition. The invention screens, by means of the latest InDel site database, and using an Asian population as the standard, 15 InDel sites with high powers of discrimination for the Asian population. The invention further includes, for each of the InDel sites, a design for a specific primer and probe combination. When compared to the prior art, the method provides the advantages of high polymorphism, good specificity, high sensitivity, ease of use, and rapidity, thereby offering an important method for implementing a microchimerism assay and individual recognition for an Asian population.

Description

用于微嵌合检测和个体识别的引物、探针、试剂盒及方法Primers, probes, kits and methods for microchimeric detection and individual recognition 技术领域Technical field
本发明涉及基因工程技术领域,具体涉及用于微嵌合检测和个体识别的引物、探针、试剂盒及方法。The present invention relates to the field of genetic engineering technology, and in particular to primers, probes, kits and methods for microchimeric detection and individual recognition.
背景技术Background technique
现代遗传学家认为,基因是DNA(脱氧核糖核酸)分子上具有遗传效应的特定核苷酸序列的总称,是具有遗传效应的DNA分子片段。基因不仅可以通过复制把遗传信息传递给下一代,还可以使遗传信息得到表达。这种遗传信息蕴含在人的骨骼、毛发、血液等所有人体组织或器官中。通过人类基因组多态性位点的差异,进行基因检测来识别不同个体,目前已被广泛运用于法医和临床试验。Modern geneticists believe that a gene is a generic term for a specific nucleotide sequence with a genetic effect on a DNA (deoxyribonucleic acid) molecule, and is a fragment of a DNA molecule with a genetic effect. Genes can not only transmit genetic information to the next generation through replication, but also enable the expression of genetic information. This genetic information is contained in all human tissues or organs such as human bones, hair, and blood. Genetic testing to identify different individuals through differences in human genomic polymorphism sites has been widely used in forensic and clinical trials.
近来已开发出多种遗传标记用于个体识别。其中,短串联重复序列(Short Tandem Repeats,STR)由于检测方法简便、快速、准确性高、扩增片段大小适中,被认为是法医DNA鉴定中最标准、最权威的途径和方法,能够解决大多数的实际问题。但是,由于STR存在高突变率(一般为10-2~10-4),检测的片段较长(100~400bp),不易实现对降解检材的DNA分型,同时嵌合率检测灵敏度在5%左右,而临床上进行微移植或者微治疗的时候,一般嵌合率需要维持在1~2%以下,无法满足要求。A variety of genetic markers have recently been developed for individual identification. Among them, Short Tandem Repeats (STR) is considered to be the most standard and authoritative way and method in forensic DNA identification because of its simplicity, rapidity, high accuracy and moderate size. Most practical problems. However, due to high mutation rate STR (typically 10-2 to 10-4), a fragment longer detected (100 ~ 400bp), for DNA typing not easy to achieve degraded sample, while the detection sensitivity of the chimeric 5 When the micro-transplant or micro-treatment is clinically performed, the general chimeric rate needs to be maintained at 1 to 2% or less, which cannot meet the requirements.
嵌合体是指同一个体体内存在不同遗传性状的细胞嵌合现象,即含有两套或两套以上染色体组的状态。其中,微嵌合是指不同个体来源的细胞成分低于1%的现象。微嵌合检测要求更高灵敏度的检测方法。因此,STR不能进行微嵌合分析。A chimera refers to a cell mosaic phenomenon in which different genetic traits exist in the same individual, that is, a state in which two or more sets of chromosomes are contained. Among them, microchimerism refers to a phenomenon in which the cellular components of different individual sources are less than 1%. Micro-chimeric detection requires a more sensitive detection method. Therefore, the STR cannot perform micro-chimeric analysis.
随着基因组研究的进展,多态性位点相继受到了广泛的关注。其中,单核苷酸多态性(Single Nucleotide Polymorphism,SNP)具有相对较低的自发突变率(10-8);而单个的SNP位点扩增产物可以控制在200bp以下,有利于降解检材的分型。然而SNP等位基因间差异只有一个碱基,因此难以设计高灵敏度的检测方案,检测灵敏度只能达到1%,仍然不适用于微嵌合 检测。而且SNP定量方法复杂,实验仪器昂贵,使用成本高,操作繁琐,通量小,并不适合在常规的法医学实验室推广。With the progress of genomic research, polymorphic sites have received extensive attention. Among them, Single Nucleotide Polymorphism (SNP) has a relatively low spontaneous mutation rate (10 -8 ); while a single SNP site amplification product can be controlled below 200 bp, which is beneficial to degradation of samples. Type of. However, the difference between SNP alleles is only one base, so it is difficult to design a highly sensitive detection scheme with a detection sensitivity of only 1%, which is still not suitable for micro-chimeric detection. Moreover, the SNP quantitative method is complicated, the experimental instrument is expensive, the use cost is high, the operation is cumbersome, the flux is small, and it is not suitable for promotion in a conventional forensic laboratory.
近年来新一代的多态性位点——插入或缺失多态性(Insertion or Deletion Polymorphisms,InDel或DIP),即基因组中插入或缺失不同类型和大小的DNA片段(4~22bp)所形成的多态性遗传标记,在法医物证鉴定、亲子鉴定和其他医学检验方面有着广泛运用。从法医学物证检验的角度来看,InDel标记具有以下特点:(1)在人类基因组中含量丰富,数量仅次于SNP;(2)与SNP具有相近的自然突变率(~2.3×10-9);(3)InDel扩增片段更短(低于160bp),更适于检测高度降解和低拷贝的DNA模板,增加DNA降解检材分型的成功率;(4)InDel位点存在显著的人群和种族差异;(5)可通过荧光PCR扩增技术进行InDel检测,技术平台普遍适用性强;(6)基于InDel位点,使用双色荧光定量PCR方法,确定区分供者和受者的特异性位点后,进行定量PCR,最低嵌合率检测可以达到0.01~0.05%。因此,近些年来日渐引起国内外许多法医学者的关注。然而,截止到目前为止,基于InDel遗传标记的商业上比较成熟的用于微嵌合检测和个体识别的试剂盒还非常少见,只有荷兰的Investigator DIP试剂盒是比较成熟的商业化产品。同时,由于遗传标记存在人群和种族的差异,Investigator DIP试剂盒对于亚洲人群来说,适用性并不是特别强。因此,研发一套适用于亚洲人群的用于微嵌合检测和个体识别的InDel遗传标记试剂盒就显得非常必要。In recent years, a new generation of polymorphic loci, Insertion or Deletion Polymorphisms (InDel or DIP), is formed by inserting or deleting DNA fragments of different types and sizes (4-22 bp) in the genome. Polymorphic genetic markers are widely used in forensic evidence identification, paternity testing and other medical tests. From the perspective of forensic evidence testing, the InDel marker has the following characteristics: (1) abundant in the human genome, second only to the SNP; (2) natural mutation rate similar to the SNP (~2.3×10 -9 ) (3) The InDel amplified fragment is shorter (less than 160bp), which is more suitable for detecting highly degraded and low-copy DNA templates, increasing the success rate of DNA degradation sample typing; (4) There are significant populations in the InDel locus. And ethnic differences; (5) InDel detection by fluorescence PCR amplification technology, the technical platform is generally applicable; (6) Based on the InDel site, using two-color fluorescence quantitative PCR method to determine the specificity of donor and recipient After the site, quantitative PCR was performed, and the minimum chimerism rate detection was 0.01 to 0.05%. Therefore, in recent years, it has attracted the attention of many forensic scientists at home and abroad. However, to date, commercially available kits for micro-chimeric detection and individual recognition based on InDel genetic markers are rare, and only the Dutch Investigator DIP kit is a relatively mature commercial product. At the same time, the Investigator DIP kit is not particularly applicable to Asian populations due to differences in population and ethnicity of genetic markers. Therefore, it is necessary to develop a set of InDel genetic marker kits for micro-chimeric detection and individual identification for the Asian population.
发明内容Summary of the invention
本发明针对现有技术中存在的上述缺陷,基于最新的InDel位点数据库,并以亚洲人群为基准,重新设计了用于微嵌合检测和个体识别的引物和探针以及检测方法。本发明的检测方法多态性强、特异性好、灵敏度高且简便快捷。The present invention is directed to the above-mentioned drawbacks existing in the prior art, based on the latest InDel site database, and based on the Asian population, redesigned primers and probes for microchimerism detection and individual recognition, and detection methods. The detection method of the invention has strong polymorphism, good specificity, high sensitivity and is simple and quick.
为此,本发明一方面提供了一种用于微嵌合检测和个体识别的引物和探针组合,其由SEQ ID NO.1-75所示的引物和探针组成。To this end, one aspect of the invention provides a primer and probe combination for microchimeric detection and individual recognition consisting of the primers and probes set forth in SEQ ID NO. 1-75.
在本发明优选的实施方案中,该引物和探针组合进一步由第1-15组引物和探针组成,其中第1组由SEQ ID NO.1-4所示的引物和SEQ ID NO.5所示的探针组成,第2组由SEQ ID NO.6-9所示的引物和SEQ ID NO.10 所示的探针组成,第3组由SEQ ID NO.11-14所示的引物和SEQ ID NO.15所示的探针组成,第4组由SEQ ID NO.16-19所示的引物和SEQ ID NO.20所示的探针组成,第5组由SEQ ID NO.21-24所示的引物和SEQ ID NO.25所示的探针组成,第6组由SEQ ID NO.26-29所示的引物和SEQ ID NO.30所示的探针组成,第7组由SEQ ID NO.31-34所示的引物和SEQ ID NO.35所示的探针组成,第8组由SEQ ID NO.36-39所示的引物和SEQ ID NO.40所示的探针组成,第9组由SEQ ID NO.41-44所示的引物和SEQ ID NO.45所示的探针组成,第10组由SEQ ID NO.46-49所示的引物和SEQ ID NO.50所示的探针组成,第11组由SEQ ID NO.51-54所示的引物和SEQ ID NO.55所示的探针组成,第12组由SEQ ID NO.56-59所示的引物和SEQ ID NO.60所示的探针组成,第13组由SEQ ID NO.61-64所示的引物和SEQ ID NO.65所示的探针组成,第14组由SEQ ID NO.66-69所示的引物和SEQ ID NO.70所示的探针组成,第15组由SEQ ID NO.71-74所示的引物和SEQ ID NO.75所示的探针组成。In a preferred embodiment of the invention, the primer and probe combination further consists of a set 1-15 set of primers and probes, wherein the first set consists of the primers set forth in SEQ ID NO. 1-4 and SEQ ID NO. The probe composition shown, the second group consists of the primers shown in SEQ ID NO. 6-9 and SEQ ID NO. The probe composition is shown, the third group consists of the primers shown in SEQ ID NO. 11-14 and the probes shown in SEQ ID NO. 15, and the fourth group consists of the primers shown in SEQ ID NO. 16-19. And probes of SEQ ID NO. 20, group 5 consists of the primers shown in SEQ ID NO. 21-24 and the probes shown in SEQ ID NO. 25, and the sixth group consists of SEQ ID NO. The primer shown in -29 and the probe shown in SEQ ID NO. 30, the seventh group consists of the primer shown in SEQ ID NO. 31-34 and the probe shown in SEQ ID NO. 35, Group 8 It consists of the primers shown in SEQ ID NO. 36-39 and the probes shown in SEQ ID NO. 40, and the ninth group consists of the primers shown in SEQ ID NO. 41-44 and the probe shown in SEQ ID NO. Needle composition, group 10 consists of the primers shown in SEQ ID NO. 46-49 and the probes shown in SEQ ID NO. 50, and the 11th group consists of the primers shown in SEQ ID NO. 51-54 and SEQ ID NO The probe composition shown in .55, the 12th group consists of the primers shown in SEQ ID NO. 56-59 and the probes shown in SEQ ID NO. 60, and the 13th group is represented by SEQ ID NO. 61-64. The primer is composed of the probe shown in SEQ ID NO. 65, and the 14th group is the primer shown in SEQ ID NO. 66-69 and SEQ ID NO. The probe composition shown by 0, the 15th group consists of the primer shown in SEQ ID NO. 71-74 and the probe shown in SEQ ID NO.
本发明基于最新的InDel位点数据库,以亚洲人群为基准,从中筛选出针对亚洲人群高个体识别率的15个InDel位点,它们分别为:N1-1(rs2308010)、N1-2(rs34855933)、N1-3(rs4646006)、N2-1(rs3042783)、N5-1(rs1610937)、N5-4(rs1610932)、N7-1(rs16458)、N9-1(rs2308112)、N11-1(rs2307696)、N11-2(rs140790)、N13-1(rs3038530)、N13-2(rs3049448)、N14-1(rs56024302)、N16-2(rs2067204)和N21-1(rs16663),括号中的rs号表示该位点在dbSNP数据库的编号。The invention is based on the latest InDel locus database, and based on the Asian population, 15 InDel loci for high individual recognition rate of Asian population are selected, which are: N1-1 (rs2308010), N1-2 (rs34855933). , N1-3 (rs4646006), N2-1 (rs3042783), N5-1 (rs1610937), N5-4 (rs1610932), N7-1 (rs16458), N9-1 (rs2308112), N11-1 (rs2307696), N11-2 (rs140790), N13-1 (rs3038530), N13-2 (rs3049448), N14-1 (rs56024302), N16-2 (rs2067204), and N21-1 (rs16663), the rs number in parentheses indicates the bit Point the number in the dbSNP database.
本发明进一步针对上述每一个InDel位点,分别设计一条共用的上游引物(F)、下游引物(R)、插入特异性引物F(+)和缺失特异性引物F(-),其中扩增片段长度(Amplified Fragment Length,AFL)为该引物与对应的上游引物或下游引物配对所得到的扩增片段长度,例如F(+)与R用来特异性扩增插入片段,R(-)与F用来特异性扩增缺失片段,F与R用来扩增非特异性片段(其中:
Figure PCTCN2016109157-appb-000001
代表插入/缺失的特异性碱基)。
The present invention further designs, for each of the above InDel sites, a common upstream primer (F), a downstream primer (R), an insertion specific primer F (+), and a deletion specific primer F (-), wherein the amplified fragment Amplified Fragment Length (AFL) is the length of the amplified fragment obtained by pairing the primer with the corresponding upstream primer or downstream primer. For example, F(+) and R are used to specifically amplify the insert, R(-) and F. Used to specifically amplify deleted fragments, F and R are used to amplify non-specific fragments (where:
Figure PCTCN2016109157-appb-000001
Represents a specific base for insertion/deletion).
针对上述亚洲人群高个体识别率的15个InDel位点,本发明设计的具体引物和探针情况如表1所示。 The specific primers and probes designed by the present invention are shown in Table 1 for the 15 InDel sites of the high individual recognition rate of the above Asian population.
表1、本发明的引物和探针情况表Table 1. Table of primers and probes of the present invention
Figure PCTCN2016109157-appb-000002
Figure PCTCN2016109157-appb-000002
Figure PCTCN2016109157-appb-000003
Figure PCTCN2016109157-appb-000003
本发明另一方面提供了一种用于微嵌合检测和个体识别的试剂盒,其包 含本发明所述的引物和探针组合。该试剂盒保存于-20℃,并由以下试剂组成。Another aspect of the invention provides a kit for microchimeric detection and individual identification, the kit of which A primer and probe combination according to the invention is included. The kit is stored at -20 ° C and consists of the following reagents.
1、全血基因组DNA提取试剂,购于QIAamp DNA Blood Mini kit试剂盒;1. Whole blood genomic DNA extraction reagent, purchased from QIAamp DNA Blood Mini kit;
2、RNase-Free ddH2O;2. RNase-Free ddH 2 O;
3、2×Super Real PreMix反应液,购于天根生化科技(北京)有限公司,货号:FP206;3, 2 × Super Real PreMix reaction solution, purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd., article number: FP206;
4、50×ROX Reference Dye,购于天根生化科技(北京)有限公司,货号:FP206;4, 50 × ROX Reference Dye, purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd., article number: FP206;
5、分别分装在相应编号离心管中的引物和探针组合。5. The primer and probe combinations are separately dispensed into the corresponding numbered centrifuge tubes.
在本发明优选的实施方案中,试剂盒中每种引物的浓度为6μM,每种探针的浓度为4μM。In a preferred embodiment of the invention, the concentration of each primer in the kit is 6 [mu]M and the concentration of each probe is 4 [mu]M.
本发明另一方面提供了本发明所述的引物和探针组合在制备微嵌合检测和个体识别试剂盒中的应用。Another aspect of the invention provides the use of the primer and probe combinations of the invention in the preparation of micro-chimeric detection and individual recognition kits.
本发明再一方面提供了本发明所述的引物和探针组合,或者本发明所述的试剂盒在微嵌合检测和个体识别中的应用。A further aspect of the invention provides the use of the primers and probe combinations of the invention, or the kits of the invention for micro-chimeric detection and individual recognition.
本发明最后一方面提供了一种微嵌合检测和个体识别的方法,其包含以下步骤:A final aspect of the invention provides a method of microchimeric detection and individual identification comprising the steps of:
1、获取待测样品的DNA。1. Obtain the DNA of the sample to be tested.
DNA提取可以采用QIAamp DNA Blood Mini kit试剂盒。DNA extraction can be performed using the QIAamp DNA Blood Mini kit.
2、采用本发明所述的引物和探针组合,或采用本发明所述的试剂盒,以步骤1中获取的DNA为模板,进行荧光PCR扩增,并收集荧光信号。2. Using the primer and probe combination of the present invention, or using the kit of the present invention, using the DNA obtained in step 1 as a template, performing fluorescent PCR amplification, and collecting the fluorescent signal.
荧光PCR扩增的体系为20uL:10uL 2×Super Real PreMix反应液(天根生化科技(北京)有限公司,货号:FP206);0.2uL 50×ROX Reference Dye(天根生化科技(北京)有限公司,货号:FP206);1uL 6uM引物F(+)/F(-);1uL 6uM引物R;1uL 4uM探针;1uL 20ng/uL DNA;用RNase-Free ddH2O补足反应体系。The system for fluorescence PCR amplification is 20uL: 10uL 2× Super Real PreMix reaction solution (Tiangen Biochemical Technology (Beijing) Co., Ltd., Item No.: FP206); 0.2uL 50×ROX Reference Dye (Tiangen Biochemical Technology (Beijing) Co., Ltd.) , Item No.: FP206); 1uL 6uM primer F(+)/F(-); 1uL 6uM primer R; 1uL 4uM probe; 1uL 20ng/uL DNA; complement the reaction system with RNase-Free ddH 2 O.
荧光PCR的反应条件为:95℃预变性15min,然后95℃变性3s—60℃退火延伸32s,共进行40个循环,在60℃处收集荧光信号。The reaction conditions of the fluorescent PCR were: pre-denaturation at 95 ° C for 15 min, followed by denaturation at 95 ° C for 3 s - 60 ° C for 32 s, for a total of 40 cycles, and the fluorescence signal was collected at 60 ° C.
3、根据Ct值判断待测样品在15个InDel位点上的多态性差异,从而对待测样品进行微嵌合检测和个体识别。 3. According to the Ct value, the polymorphism difference of the sample to be tested at 15 InDel sites is determined, so that the sample to be tested is subjected to micro-chimeric detection and individual recognition.
通过Ct值来判断每个遗传标记阳性样本和阴性样本的Ct值区间范围,阳性样本Ct值落在24-29之间,阴性样本Ct值在38以上,阳性样本和阴性样本Ct值相差12以上,表示引物和探针的特异性良好。The Ct value of each genetic marker is used to judge the range of Ct values of positive and negative samples of each genetic marker. The Ct value of positive samples falls between 24-29, the Ct value of negative samples is above 38, and the Ct values of positive and negative samples differ by more than 12 , indicating that the primers and probes have good specificity.
在本发明优选的实施方案中,采用的引物和探针是针对亚洲人群高个体识别率的15个InDel位点设计的。In a preferred embodiment of the invention, the primers and probes employed are designed for 15 InDel sites with high individual recognition rates for Asian populations.
在本发明进一步优选的实施方案中,每种引物的浓度为6μM,每种探针的浓度为4μM。In a further preferred embodiment of the invention, each primer has a concentration of 6 [mu]M and a concentration of 4 [mu]M per probe.
由上述描述可知,与现有技术相比,本发明具备如下优点。As apparent from the above description, the present invention has the following advantages as compared with the prior art.
1、多态性强:通过本发明筛选的15个InDel位点,对随机选取的94个样本进行基因频率测试,结果表明这15个InDel位点等位基因频率分布均衡,多态性强。根据这15个InDel位点的多态性信息,能够进行微嵌合检测和个体识别。1. Strong polymorphism: Through the 15 InDel loci screened by the present invention, the random frequency selection of 94 samples was tested for gene frequency, and the results showed that the 15 InDel loci alleles were evenly distributed and the polymorphism was strong. Based on the polymorphism information of these 15 InDel sites, microchimeric detection and individual recognition can be performed.
2、特异性好:通过本发明筛选的15个InDel位点,对阳性样本和阴性样本进行检测,结果表明特异性好、稳定性强、重复性好,分型结果准确(在测序结果基础上进行比较)。2. Good specificity: The positive and negative samples were detected by the 15 InDel sites screened by the present invention, and the results showed that the specificity was good, the stability was strong, the repeatability was good, and the typing results were accurate (based on the sequencing results). Compare).
3、灵敏度高:进行嵌合状态分析时,利用本发明筛选的15个InDel位点,进行荧光PCR扩增,当模板量仅为140ng时,即可进行精确的定量分析,最低嵌合率检测可达0.025%。3. High sensitivity: When performing chimeric state analysis, 15 InDel sites screened by the present invention are used for fluorescence PCR amplification. When the template amount is only 140 ng, accurate quantitative analysis can be performed, and the minimum chimeric rate detection can be performed. Up to 0.025%.
4、本发明的检测方法采用双荧光标记扩增技术,该技术简便、快捷,只需一台Applied Biosystems 7500Real Time PCR System即可,结果进行自动分析,能够保证不同实验室数据的准确性。4. The detection method of the invention adopts double fluorescent label amplification technology, which is simple and fast, and only needs one Applied Biosystems 7500 Real Time PCR System, and the result is automatically analyzed, which can ensure the accuracy of different laboratory data.
附图说明DRAWINGS
图1:本发明用于检测引物和探针特异性的PCR扩增结果图。Figure 1: Schematic diagram of PCR amplification results for the detection of primer and probe specificity of the present invention.
图2:本发明试剂盒用于个体识别检测的PCR扩增结果图。Figure 2: A diagram of PCR amplification results for the individual recognition assay of the kit of the invention.
图3:本发明遗传标记N13-1(+)的检测结果图。Fig. 3 is a graph showing the results of detection of the genetic marker N13-1(+) of the present invention.
图4:本发明遗传标记N13-1(+)的标准品(100%、90%、50%、10%、1%、0.1%、0.05%、0.025%)扩增曲线图。Figure 4: Amplification plot of the standard (100%, 90%, 50%, 10%, 1%, 0.1%, 0.05%, 0.025%) of the genetic marker N13-1(+) of the present invention.
具体实施方式detailed description
下面通过实施例对本发明作进一步的详细说明,旨在用于说明本发明 而非限定本发明。应当指出,对于本领域技术人员而言,在不脱离本发明原理的前提下,还可以对本发明进行若干改进和修饰,这些改进和修饰也同样落入本发明的保护范围之内。The invention is further illustrated by the following examples, which are intended to illustrate the invention. It is not intended to limit the invention. It is to be noted that a number of modifications and variations of the present invention may be made by those skilled in the art without departing from the scope of the invention.
实施例1:引物的设计与合成Example 1: Design and Synthesis of Primers
(一)InDel位点筛选(1) Screening of InDel sites
采用如下原则对InDel位点进行筛选:The InDel locus is screened using the following principles:
1、InDel等位基因片段长度差异(插入或缺失碱基数目)大于3bp小于30bp;1. The difference in length of the InDel allele fragment (number of inserted or deleted bases) is greater than 3 bp and less than 30 bp;
2、位于人类22条常染色体上;2, located on 22 human autosomes;
3、同一条染色体上的InDel位点间距大于5Mb;3. The spacing of InDel sites on the same chromosome is greater than 5Mb;
4、最小等位基因频率(Minimum allele frequency,MAF)介于0.30到0.50之间(以东亚人群为基准);4. The minimum allele frequency (MAF) is between 0.30 and 0.50 (based on the East Asian population);
5、总位点数不少于30个,累积个体识别率达到0.9999以上;5, the total number of sites is not less than 30, the cumulative individual recognition rate reaches 0.9999 or more;
6、同一染色体上不形成连锁,在人群中的分布符合Hardy-Weinberg遗传平衡;6. There is no linkage on the same chromosome, and the distribution in the population is consistent with the Hardy-Weinberg genetic balance;
7、避免InDel位点与某些特殊的疾病表型相关联,多态性位点最好位于内含子区域。7. Avoid InDel sites associated with certain disease phenotypes, and polymorphic sites are preferably located in intron regions.
采用上述原则,分别通过http://www.ensembl.org/index.html和http://www.ncbi.nlm.nih.gov/projects/SNP/所示的网址,对多态性较强的InDel位点进行初步筛选,最终选定了15个InDel位点,分别为:N1-1(rs2308010)、N1-2(rs34855933)、N1-3(rs4646006)、N2-1(rs3042783)、N5-1(rs1610937)、N5-4(rs1610932)、N7-1(rs16458)、N9-1(rs2308112)、N11-1(rs2307696)、N11-2(rs140790)、N13-1(rs3038530)、N13-2(rs3049448)、N14-1(rs56024302)、N16-2(rs2067204)、N21-1(rs16663),括号中的rs号表示该位点在dbSNP数据库的编号。Using the above principles, the polymorphisms are stronger through the URLs shown at http://www.ensembl.org/index.html and http://www.ncbi.nlm.nih.gov/projects/SNP/ respectively. The InDel locus was initially screened, and finally 15 InDel loci were selected: N1-1 (rs2308010), N1-2 (rs34855933), N1-3 (rs4646006), N2-1 (rs3042783), N5- 1 (rs1610937), N5-4 (rs1610932), N7-1 (rs16458), N9-1 (rs2308112), N11-1 (rs2307696), N11-2 (rs140790), N13-1 (rs3038530), N13-2 (rs3049448), N14-1 (rs56024302), N16-2 (rs2067204), N21-1 (rs16663), the rs number in parentheses indicates the number of the site in the dbSNP database.
(二)样本选择、基因频率测试和引物序列修改(2) Sample selection, gene frequency test and primer sequence modification
随机选取94个中国人群DNA样本,进行扩增和基因测序。采用初步选定的引物对94个健康人基因组DNA样本进行检测,用以评估引物的扩增效率和各位点的基因频率。A total of 94 Chinese population DNA samples were randomly selected for amplification and gene sequencing. 94 healthy human genomic DNA samples were tested using the initially selected primers to assess primer amplification efficiency and gene frequency at each locus.
1、DNA提取 1, DNA extraction
DNA提取按照QIAamp DNA Blood Mini kit试剂盒进行,随后采用RNase-Free ddH2O稀释到20ng/uL备用。DNA extraction was performed according to the QIAamp DNA Blood Mini kit, followed by dilution with RNase-Free ddH 2 O to 20 ng/uL for use.
2、PCR扩增体系2. PCR amplification system
采用25uL的PCR扩增体系:2.5uL 10×buffer反应液;0.75uL 10mM dNTP;1uL 5uM引物F;1.8uL 5uM引物R;1.4uL 5uM引物F(+)/F(-);2uL DNA;0.2uL Hot start Taq;1uL Mg2+;0.1uL DMSO,用RNase-Free ddH2O补足反应体系。25 uL PCR amplification system: 2.5 uL 10×buffer reaction solution; 0.75 uL 10 mM dNTP; 1 uL 5 uM primer F; 1.8 uL 5 uM primer R; 1.4 uL 5 uM primer F(+)/F(-); 2 uL DNA; uL Hot start Taq; 1 uL Mg 2+ ; 0.1 uL DMSO, supplemented with RNase-Free ddH 2 O.
3、PCR反应条件3. PCR reaction conditions
采用如下的PCR反应条件:95℃预变性30s,然后95℃变性30s—58℃退火30s—68℃延伸30s,共进行30个循环,最后68℃延伸5min。The following PCR reaction conditions were adopted: pre-denaturation at 95 ° C for 30 s, followed by denaturation at 95 ° C for 30 s - 58 ° C for 30 s - 68 ° C for 30 s, for a total of 30 cycles, and finally at 68 ° C for 5 min.
4、电泳检测和引物序列修改4, electrophoresis detection and primer sequence modification
PCR产物经2%琼脂糖电泳30min后进行检测,验证设计的特异性引物是否合适。以一代测序结果为准,针对电泳假阳性和假阴性的情况,修改引物序列,重新进行检测。The PCR product was electrophoresed on 2% agarose for 30 min to verify whether the specific primers were suitable. Based on the sequencing results of the first generation, the primer sequences were modified and retested for the case of electrophoresis false positives and false negatives.
经过检测和修改之后,最终确定的15个InDel位点的引物及探针序列如表1所示,委托上海英骏生物技术有限公司合成上述引物和探针。After detection and modification, the primers and probe sequences of the finally determined 15 InDel sites are shown in Table 1. The above primers and probes were synthesized by Shanghai Yingjun Biotechnology Co., Ltd.
分别用15个InDel位点的引物和探针对94个样本进行检测,结果表明等位基因频率分布比较均衡,具体多态性信息如表2所示。其中:“+”代表插入多态性;“-”代表缺失多态性;“+/+”代表插入纯合子多态性;“+/-”代表插入/缺失杂合子多态性;“-/-”代表缺失纯合子多态性。94 samples were detected by primers and probes from 15 InDel sites, respectively. The results showed that the allele frequency distribution was relatively balanced. The specific polymorphism information is shown in Table 2. Wherein: "+" stands for insertion polymorphism; "-" stands for deletion polymorphism; "+/+" stands for insertion homozygous polymorphism; "+/-" stands for insertion/deletion heterozygosity polymorphism; "- /-" represents a deletion homozygous polymorphism.
表2 15个InDel位点的多态性信息(测序结果)Table 2 Polymorphism information of 15 InDel loci (sequencing results)
Figure PCTCN2016109157-appb-000004
Figure PCTCN2016109157-appb-000004
Figure PCTCN2016109157-appb-000005
Figure PCTCN2016109157-appb-000005
实施例2:引物和探针特异性测试Example 2: Primer and probe specificity testing
在实施例1的测序结果下,分别选取5个插入纯合子、缺失纯合子和杂合子,进行荧光PCR,用于检测引物和探针的特异性。Under the sequencing results of Example 1, five insertion homozygotes, deletion homozygotes and heterozygotes were selected for fluorescence PCR to detect the specificity of the primers and probes.
1、荧光PCR扩增体系1. Fluorescent PCR amplification system
采用20uL的荧光PCR扩增体系:10uL 2×Super Real PreMix反应液(天根生化科技(北京)有限公司,货号:FP206);0.2uL 50×ROX Reference Dye(天根生化科技(北京)有限公司,货号:FP206);1uL 6uM引物F(+)/F(-);1uL 6uM引物R;1uL 4uM探针;1uL 20ng/uL DNA;用RNase-Free ddH2O补足反应体系。Adopt 20uL fluorescent PCR amplification system: 10uL 2×Super Real PreMix reaction solution (Tiangen Biochemical Technology (Beijing) Co., Ltd., Item No.: FP206); 0.2uL 50×ROX Reference Dye (Tiangen Biochemical Technology (Beijing) Co., Ltd. , Item No.: FP206); 1uL 6uM primer F(+)/F(-); 1uL 6uM primer R; 1uL 4uM probe; 1uL 20ng/uL DNA; complement the reaction system with RNase-Free ddH 2 O.
2、荧光PCR反应条件2, fluorescent PCR reaction conditions
采用如下的荧光PCR反应条件:95℃预变性15min,然后95℃变性3s—60℃退火延伸32s,共进行40个循环,在60℃处收集荧光信号。The following fluorescent PCR reaction conditions were employed: pre-denaturation at 95 ° C for 15 min, followed by denaturation at 95 ° C for 3 s - 60 ° C for 32 s, for a total of 40 cycles, and the fluorescence signal was collected at 60 ° C.
3、引物和探针特异性判断3. Primer and probe specific judgment
通过Ct值来判断每个遗传标记阳性样本和阴性样本的Ct值区间范围,阳性样本Ct值落在24-29之间,阴性样本Ct值在38以上,阳性样本和阴性样本Ct值相差12以上,表示引物和探针的特异性良好。The Ct value of each genetic marker is used to judge the range of Ct values of positive and negative samples of each genetic marker. The Ct value of positive samples falls between 24-29, the Ct value of negative samples is above 38, and the Ct values of positive and negative samples differ by more than 12 , indicating that the primers and probes have good specificity.
以N1-2(+)插入遗传标记为例,阳性样本(插入纯合子和杂合子)的Ct值落在范围26-28内(参见说明书附图1a),阴性样本(缺失纯合子)的Ct值检测不到(即在40个PCR循环数下,没有检测到荧光信号,Ct值大于40)(参见说明书附图1b),表明引物和探针的特异性良好。Taking the N1-2 (+) insertion of the genetic marker as an example, the Ct values of the positive samples (inserted homozygotes and heterozygotes) fall within the range 26-28 (see Figure 1a of the specification), and the negative samples (deleted homozygous) Ct The values were not detectable (i.e., no fluorescence signal was detected at 40 PCR cycles, and the Ct value was greater than 40) (see Figure 1b of the specification), indicating that the primers and probes were of good specificity.
实施例3:本发明试剂盒的组成Example 3: Composition of the kit of the present invention
本发明用于微嵌合检测和个体识别的InDel遗传标记试剂盒,保存于-20℃,由以下试剂组成。The InDel genetic labeling kit for microchimerism detection and individual recognition of the present invention is stored at -20 ° C and consists of the following reagents.
1、全血基因组DNA提取试剂:购于QIAamp DNA Blood Mini kit试剂盒。1. Whole blood genomic DNA extraction reagent: purchased from QIAamp DNA Blood Mini kit.
2、RNase-Free ddH2O。2. RNase-Free ddH 2 O.
3、2×Super Real PreMix反应液,购于天根生化科技(北京)有限公司,货号:FP206。3, 2 × Super Real PreMix reaction solution, purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd., article number: FP206.
4、50×ROX Reference Dye,购于天根生化科技(北京)有限公司,货 号:FP206。4, 50 × ROX Reference Dye, purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd., goods No.: FP206.
5、分别分装在相应编号离心管中的引物和探针组合,每种引物的浓度为6uM,每种探针浓度为4uM。5. The primer and probe combinations were separately dispensed in the corresponding numbered centrifuge tubes. The concentration of each primer was 6 uM, and the concentration of each probe was 4 uM.
实施例4:本发明试剂盒用于个体识别的检测Example 4: The kit of the invention is used for the detection of individual identification
随机选取两个不同来源的DNA样本(分别命名为A和B),用本发明试剂盒中的InDel遗传标记进行多态性检测。Two different sources of DNA samples (designated A and B, respectively) were randomly selected and polymorphism was detected using the InDel genetic marker in the kit of the present invention.
荧光PCR扩增体系及反应条件同实施例2。PCR扩增反应后,对于每一个遗传标记,扩增后可能出现四种结果,具体参见说明书附图2。图2a中,样本A和B均为阳性;图2b中,样本A和B均为阴性;图2c中,样本A为阳性,样本B为阴性;图2d中,样本A为阴性,样本B为阳性。图2a和2b没有多态性差异,图2c和2d具有多态性差异,根据多态性差异即可判断出样本是否来源于不同个体。The fluorescent PCR amplification system and reaction conditions were the same as in Example 2. After the PCR amplification reaction, for each genetic marker, four results may appear after amplification, as shown in Figure 2 of the specification. In Figure 2a, both samples A and B are positive; in Figure 2b, samples A and B are negative; in Figure 2c, sample A is positive and sample B is negative; in Figure 2d, sample A is negative and sample B is negative. Positive. Figures 2a and 2b show no polymorphism differences, and Figures 2c and 2d have polymorphic differences, and it is possible to determine whether the samples are derived from different individuals based on the polymorphism differences.
根据Ct值进行判断,在15个InDel位点中,样本A和样本B有14个遗传标记(N1-1(+)、N1-2(-)、N1-3(-)、N2-1(+)、N2-1(-)、N5-4(+)、N7-1(+)、N9-1(+)、N11-1(-)、N11-2(-)、N13-1(+)、N13-1(-)、N14-1(+)、N16-2(-))具有多态性差异。因此,可判断样本A和样本B来源于不同的个体。According to the Ct value, among the 15 InDel sites, sample A and sample B have 14 genetic markers (N1-1(+), N1-2(-), N1-3(-), N2-1( +), N2-1(-), N5-4(+), N7-1(+), N9-1(+), N11-1(-), N11-2(-), N13-1(+ ), N13-1 (-), N14-1 (+), and N16-2 (-) have polymorphic differences. Therefore, it can be judged that the sample A and the sample B are derived from different individuals.
实施例5:引物和探针准确性和灵敏性测试Example 5: Primer and probe accuracy and sensitivity tests
选取40对DNA样本进行InDel遗传标记定性检测,以获得每对样本的InDel位点多态性信息。40 pairs of DNA samples were selected for qualitative detection of InDel genetic markers to obtain InDel locus polymorphism information for each pair of samples.
针对每一对样本,选出可用的遗传标记(可用遗传标记需符合以下特点:Ct<28阳性样本定为受者,Ct>38阴性样本定为供者),以不同比例混合,得到不同比例的标准品,通过荧光PCR进行灵敏度和准确性检测。同时,为了达到10-5的检测灵敏度,初始DNA模板的量至少为140ng。For each pair of samples, select the available genetic markers (the available genetic markers should meet the following characteristics: Ct<28 positive samples are designated as recipients, Ct>38 negative samples are designated as donors), mixed in different proportions, and different ratios are obtained. The standard is tested for sensitivity and accuracy by fluorescence PCR. Meanwhile, in order to achieve a detection sensitivity of 10 -5 , the amount of the initial DNA template is at least 140 ng.
选择其中一对样本为例(样本命名为C和D),具体实施方法如下。Take a pair of samples as an example (the samples are named C and D), and the specific implementation method is as follows.
1、对样本C和样本D进行InDel位点多态性测试1. Perform InDel locus polymorphism test on sample C and sample D.
荧光PCR反应体系及条件同实施例2。以样本C为受者,样本D为供着,按照Ct值的大小(C:Ct<28阳性样本;D:Ct>38阴性样本),选出可用的遗传标记。The fluorescent PCR reaction system and conditions were the same as in Example 2. With sample C as the recipient and sample D as the donor, the available genetic markers were selected according to the size of the Ct value (C: Ct < 28 positive samples; D: Ct > 38 negative samples).
2、标准品构建2, standard product construction
针对样本C和样本D,以不同比例混合(受者C/供者D:90%、50%、 10%、1%、0.1%、0.05%、0.025%),得到不同比例的浓度为20ng/uL的标准品。For sample C and sample D, mix in different proportions (recipient C/donor D: 90%, 50%, 10%, 1%, 0.1%, 0.05%, 0.025%), a standard of 20 ng/uL in different ratios was obtained.
3、通过定量分析的方法检测引物和探针的准确性和灵敏性3. Detect the accuracy and sensitivity of primers and probes by quantitative analysis
将制备的嵌合比例分别为100%、90%、50%、10%、1%、0.1%、0.05%、0.025%的标准品作为定量分析的模板,同时以RNase-Free ddH2O为模板作为空白对照。为了达到140ng DNA初始模板(10-5的检测灵敏度),需添加7uL 20ng/uL的标准品,其它荧光PCR反应体系及条件同实施例2。Standards prepared with chimeric ratios of 100%, 90%, 50%, 10%, 1%, 0.1%, 0.05%, and 0.025% were used as templates for quantitative analysis, and RNase-Free ddH 2 O was used as a template. As a blank control. In order to reach the 140 ng DNA initial template (detection sensitivity of 10 -5 ), 7 uL of 20 ng/uL standard was added, and other fluorescent PCR reaction systems and conditions were the same as in Example 2.
4、定量分析4. Quantitative analysis
通过荧光PCR,获得不同比例的标准品检测所得的遗传标记和内参基因的Ct值,并计算两者所得Ct值的差值(ΔCt)。By PCR, the Ct values of the genetic markers and the internal reference genes detected by different ratios of the standards were obtained, and the difference (ΔCt) of the Ct values obtained by the two was calculated.
说明书附图3为遗传标记N13-1(+)的检测结果。看图3可以看出,遗传标记N13-1(+)和内参基因扩增曲线形态良好,PCR产物特异性高、无非特异性扩增,同时对照空白组无扩增。Figure 3 of the specification shows the detection results of the genetic marker N13-1(+). As can be seen from Figure 3, the genetic marker N13-1(+) and the internal reference gene amplification curve were in good shape, the PCR product was highly specific, and there was no non-specific amplification, while the control blank group had no amplification.
说明书附图4为遗传标记N13-1(+)的标准品扩增曲线。图中显示,标准品扩增曲线形态良好。以C作为手术移植前的样本,CD作为移植后的样本,根据移植后与移植前ΔCt的差值(ΔΔCt),可以计算获得CD嵌合率%=2-ΔΔCt×100%,其中ΔΔCt=ΔCt移植后-ΔCt移植前=(Ct标记基因移植后-Ct内参基因移植后)-(Ct标记基因移植前-Ct内参基因移植前)。通过比较理论值和荧光PCR计算获得的测试值,可以用来判断各个遗传标记的灵敏度和准确性。Figure 4 is a standard amplification curve of the genetic marker N13-1(+). The figure shows that the standard amplification curve is in good shape. Using C as a pre-transplant sample, CD as a post-transplant sample, according to the difference (ΔΔCt) between post-transplant and pre-transplant ΔCt, the CD mosaic rate %=2 -ΔΔCt ×100% can be calculated, where ΔΔCt=ΔCt Post-transplantation- ΔCt pre- transplantation = ( after Ct- tag gene transplantation- Ct internal reference gene transplantation )-( pre- Ct marker gene transplantation- Ct internal reference gene transplantation ). The test values obtained by comparing theoretical values with fluorescent PCR can be used to determine the sensitivity and accuracy of each genetic marker.
对于N13-1(+)遗传标记,测试值分别为93.34%(理论90%)、65.19%(理论50%)、13.25%(理论10%)、0.9452%(理论1%)、0.1053%(理论0.1%)、0.0598%(理论0.05%)以及0.0282%(理论0.025%),表明引物和探针测试准确性良好,灵敏度可以达到0.025%左右。 For the N13-1(+) genetic marker, the test values were 93.34% (theoretical 90%), 65.19% (theoretical 50%), 13.25% (theoretical 10%), 0.9452% (theoretical 1%), and 0.1053% (theoretical). 0.1%), 0.0598% (theoretical 0.05%) and 0.0282% (theoretical 0.025%), indicating that the primers and probes have good test accuracy, and the sensitivity can reach about 0.025%.
Figure PCTCN2016109157-appb-000006
Figure PCTCN2016109157-appb-000006
Figure PCTCN2016109157-appb-000007
Figure PCTCN2016109157-appb-000007
Figure PCTCN2016109157-appb-000008
Figure PCTCN2016109157-appb-000008
Figure PCTCN2016109157-appb-000009
Figure PCTCN2016109157-appb-000009
Figure PCTCN2016109157-appb-000010
Figure PCTCN2016109157-appb-000010
Figure PCTCN2016109157-appb-000011
Figure PCTCN2016109157-appb-000011
Figure PCTCN2016109157-appb-000012
Figure PCTCN2016109157-appb-000012
Figure PCTCN2016109157-appb-000013
Figure PCTCN2016109157-appb-000013
Figure PCTCN2016109157-appb-000014
Figure PCTCN2016109157-appb-000014
Figure PCTCN2016109157-appb-000015
Figure PCTCN2016109157-appb-000015
Figure PCTCN2016109157-appb-000016
Figure PCTCN2016109157-appb-000016

Claims (10)

  1. 一种用于微嵌合检测和个体识别的引物和探针组合,其由SEQ ID NO.1-75所示的引物和探针组成。A primer and probe combination for microchimeric detection and individual recognition consisting of the primers and probes set forth in SEQ ID NO. 1-75.
  2. 根据权利要求1所述的引物和探针组合,其进一步由第1-15组引物和探针组成,其中第1组由SEQ ID NO.1-4所示的引物和SEQ ID NO.5所示的探针组成,第2组由SEQ ID NO.6-9所示的引物和SEQ ID NO.10所示的探针组成,第3组由SEQ ID NO.11-14所示的引物和SEQ ID NO.15所示的探针组成,第4组由SEQ ID NO.16-19所示的引物和SEQ ID NO.20所示的探针组成,第5组由SEQ ID NO.21-24所示的引物和SEQ ID NO.25所示的探针组成,第6组由SEQ ID NO.26-29所示的引物和SEQ ID NO.30所示的探针组成,第7组由SEQ ID NO.31-34所示的引物和SEQ ID NO.35所示的探针组成,第8组由SEQ ID NO.36-39所示的引物和SEQ ID NO.40所示的探针组成,第9组由SEQ ID NO.41-44所示的引物和SEQ ID NO.45所示的探针组成,第10组由SEQ ID NO.46-49所示的引物和SEQ ID NO.50所示的探针组成,第11组由SEQ ID NO.51-54所示的引物和SEQ ID NO.55所示的探针组成,第12组由SEQ ID NO.56-59所示的引物和SEQ ID NO.60所示的探针组成,第13组由SEQ ID NO.61-64所示的引物和SEQ ID NO.65所示的探针组成,第14组由SEQ ID NO.66-69所示的引物和SEQ ID NO.70所示的探针组成,第15组由SEQ ID NO.71-74所示的引物和SEQ ID NO.75所示的探针组成。The primer and probe combination according to claim 1, further comprising a group 1-15 primer and a probe, wherein the first group is the primer set forth in SEQ ID NO. 1-4 and the SEQ ID NO. The probe composition is shown, the second group consists of the primers shown in SEQ ID NO. 6-9 and the probes shown in SEQ ID NO. 10, and the third group consists of the primers shown in SEQ ID NO. 11-14 and The probe composition shown in SEQ ID NO. 15 is composed of the primer set forth in SEQ ID NO. 16-19 and the probe represented by SEQ ID NO. 20, and the fifth group consists of SEQ ID NO. 21- The primer shown in Figure 24 and the probe shown in SEQ ID NO. 25, the sixth group consists of the primer shown in SEQ ID NO. 26-29 and the probe shown in SEQ ID NO. 30, and the seventh group consists of The primer shown in SEQ ID NO. 31-34 and the probe shown in SEQ ID NO. 35, the eighth group consists of the primer shown in SEQ ID NO. 36-39 and the probe shown in SEQ ID NO. Composition, Group 9 consists of the primers shown in SEQ ID NO. 41-44 and the probes shown in SEQ ID NO. 45, and Group 10 consists of the primers shown in SEQ ID NO. 46-49 and SEQ ID NO. The probe composition shown in Figure 50, the 11th group is represented by the primers shown in SEQ ID NO. 51-54 and SEQ ID NO. Probe composition, group 12 consists of the primers shown in SEQ ID NO. 56-59 and the probes shown in SEQ ID NO. 60, and the 13th group consists of the primers and SEQ ID shown in SEQ ID NO. 61-64. The probe composition shown in NO. 65, the 14th group consists of the primers shown in SEQ ID NO. 66-69 and the probe shown in SEQ ID NO. 70, and the 15th group is represented by SEQ ID NO. 71-74. The primer shown is composed of the probe shown in SEQ ID NO.
  3. 根据权利要求1或2所述的引物和探针组合,其是针对亚洲人群高个体识别率的15个InDel位点设计的。The primer and probe combination according to claim 1 or 2, which is designed for 15 InDel sites with high individual recognition rate in Asian populations.
  4. 一种用于微嵌合检测和个体识别的试剂盒,其包含权利要求1-3中任一项所述的引物和探针组合。A kit for microchimeric detection and individual recognition comprising the primer and probe combination of any of claims 1-3.
  5. 根据权利要求4所述的试剂盒,其中每种引物的浓度为6μM,每种探针的浓度为4μM。 The kit according to claim 4, wherein each primer has a concentration of 6 μM and each probe has a concentration of 4 μM.
  6. 权利要求1-3中任一项所述的引物和探针组合在制备微嵌合检测和个体识别试剂盒中的应用。Use of the primer and probe combination of any of claims 1-3 in the preparation of a microchimeric detection and individual recognition kit.
  7. 权利要求1-3中任一项所述的引物和探针组合,或者权利要求4或5所述的试剂盒在微嵌合检测和个体识别中的应用。Use of the primer and probe combination according to any one of claims 1 to 3, or the kit of claim 4 or 5 in microchimeric detection and individual recognition.
  8. 一种微嵌合检测和个体识别方法,其包含以下步骤:A microchimeric detection and individual identification method comprising the following steps:
    (1)获取待测样品DNA;(1) obtaining DNA of the sample to be tested;
    (2)采用权利要求1-3中任一项所述的引物和探针组合,或采用权利要求4或5所述的试剂盒,以步骤(1)中获取的DNA为模板,进行荧光PCR扩增,并收集荧光信号;(2) using the primer and probe combination according to any one of claims 1 to 3, or using the kit according to claim 4 or 5, using the DNA obtained in the step (1) as a template for performing fluorescent PCR Amplify and collect fluorescent signals;
    (3)根据Ct值判断待测样品在15个InDel位点上的多态性差异,从而对待测样品进行微嵌合检测和个体识别。(3) According to the Ct value, the polymorphism difference of the sample to be tested at 15 InDel sites is determined, so that the sample to be tested is subjected to micro-chimeric detection and individual recognition.
  9. 根据权利要求8所述的方法,其中采用的引物和探针是针对亚洲人群高个体识别率的15个InDel位点设计的。The method of claim 8 wherein the primers and probes employed are designed for 15 InDel sites for high individual recognition rates in Asian populations.
  10. 根据权利要求8或9所述的方法,其中每种引物的浓度为6μM,每种探针的浓度为4μM。 The method according to claim 8 or 9, wherein the concentration of each primer is 6 μM, and the concentration of each probe is 4 μM.
PCT/CN2016/109157 2016-04-27 2016-12-09 Primer, probe, kit, and method for microchimerism assay and individual recognition WO2017185758A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610268840.5A CN105861675A (en) 2016-04-27 2016-04-27 Primers, probe, kit and method for microchimerism detection and individual recognition
CN201610268840.5 2016-04-27

Publications (1)

Publication Number Publication Date
WO2017185758A1 true WO2017185758A1 (en) 2017-11-02

Family

ID=56629313

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/109157 WO2017185758A1 (en) 2016-04-27 2016-12-09 Primer, probe, kit, and method for microchimerism assay and individual recognition

Country Status (2)

Country Link
CN (1) CN105861675A (en)
WO (1) WO2017185758A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114574595A (en) * 2022-03-08 2022-06-03 中国人民解放军军事科学院军事医学研究院 Application of human chromosome InDel gene locus, primer group, product thereof and individual identification method of test material

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105861675A (en) * 2016-04-27 2016-08-17 上海荻硕贝肯生物科技有限公司 Primers, probe, kit and method for microchimerism detection and individual recognition
CN113265474B (en) * 2021-07-19 2021-11-02 深圳荻硕贝肯精准医学有限公司 Detection primer group and probe group for digital PCR (polymerase chain reaction) chimerism rate and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101671736A (en) * 2009-10-15 2010-03-17 北京市道培医院 Gene detection kit used for detecting cell chimerism or individual recognition
CN101956005A (en) * 2010-08-13 2011-01-26 司法部司法鉴定科学技术研究所 Fluorescently-labeled insertion/deletion (InDel) genetic polymorphism locus composite amplification system and application thereof
CN103468800A (en) * 2013-08-23 2013-12-25 四川大学 Forensic medicine composite detection kit based on 20 multiple insertion/delection genetic markers
CN104131067A (en) * 2013-05-03 2014-11-05 司法部司法鉴定科学技术研究所 Fluorescently-labeled X-InDel locus composite amplification system and application thereof
CN105861675A (en) * 2016-04-27 2016-08-17 上海荻硕贝肯生物科技有限公司 Primers, probe, kit and method for microchimerism detection and individual recognition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101575643A (en) * 2009-05-31 2009-11-11 中国人民解放军第二军医大学 Method for detecting the chimerism rate of recipients after allogeneic hematopoietic stem cell transplantation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101671736A (en) * 2009-10-15 2010-03-17 北京市道培医院 Gene detection kit used for detecting cell chimerism or individual recognition
CN101956005A (en) * 2010-08-13 2011-01-26 司法部司法鉴定科学技术研究所 Fluorescently-labeled insertion/deletion (InDel) genetic polymorphism locus composite amplification system and application thereof
CN104131067A (en) * 2013-05-03 2014-11-05 司法部司法鉴定科学技术研究所 Fluorescently-labeled X-InDel locus composite amplification system and application thereof
CN103468800A (en) * 2013-08-23 2013-12-25 四川大学 Forensic medicine composite detection kit based on 20 multiple insertion/delection genetic markers
CN105861675A (en) * 2016-04-27 2016-08-17 上海荻硕贝肯生物科技有限公司 Primers, probe, kit and method for microchimerism detection and individual recognition

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHEN, K. ET AL.: "PolyScan: An automatic indel and SNP detection approach to the analysis of human resequencing data", GENOME RESEARCH, vol. 17, 31 December 2007 (2007-12-31), pages 659 - 666, XP055434439 *
HONG, LI ET AL.: "Genetic Polymorphisms of 30 Indel Loci in Guangdong Han Population", JOURNAL OF SUN YAT-SEN UNIVERSITY(MEDICAL SCIENCES, vol. 34, no. 2, 31 March 2013 (2013-03-31), pages 299 - 304 *
SUN, KUAN ET AL.: "Progress in InDel as a New Generation of Genetic Marker", JOURNAL OF FORENSIC MEDICINE, vol. 29, no. 2, 30 April 2013 (2013-04-30), pages 134 - 139 and 143 *
ZHAO, SHUMIN ET AL.: "InDel_typer30: A Multiplex PCR System for DNA Identification among Five Chinese Populations", JOURNAL OF FORENSIC MEDICINE, vol. 26, no. 5, 31 October 2010 (2010-10-31), pages 343 - 348 and 356 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114574595A (en) * 2022-03-08 2022-06-03 中国人民解放军军事科学院军事医学研究院 Application of human chromosome InDel gene locus, primer group, product thereof and individual identification method of test material
CN114574595B (en) * 2022-03-08 2022-12-02 中国人民解放军军事科学院军事医学研究院 Application of human chromosome InDel gene locus, primer group, product thereof and individual identification method of test material

Also Published As

Publication number Publication date
CN105861675A (en) 2016-08-17

Similar Documents

Publication Publication Date Title
CN107488711B (en) Method for detecting genotype of point mutation and kit thereof
AU2016250529A1 (en) Method to increase sensitivity of next generation sequencing
CN108913757B (en) Primer group and detection kit for chromosome aneuploid number abnormality and application thereof
CN110218781B (en) Composite amplification system of 21 micro haplotype sites, next generation sequencing and typing kit and typing method
CN105378111A (en) Methods of performing polymerase chain reaction and related uses thereof
CN113293204B (en) Primer composition, kit and method for detecting microsatellite instability based on second-generation sequencing platform
WO2018147438A1 (en) Pcr primer set for hla gene, and sequencing method using same
WO2017185758A1 (en) Primer, probe, kit, and method for microchimerism assay and individual recognition
CN108060237B (en) Forensic medicine composite detection kit based on 55Y chromosome SNP genetic markers
US20200270697A1 (en) Method for predicting organ transplant rejection using next-generation sequencing
CN110564861A (en) Fluorescence labeling composite amplification kit for human Y chromosome STR locus and InDel locus and application thereof
CN107988385B (en) Method for detecting marker of PLAG1 gene Indel of beef cattle and special kit thereof
CN107164473A (en) The Primer composition and kit of a kind of type of detection CALR genes 1 mutation
CN107841552B (en) Primer combination, MLPA probe, gene chip and kit for detecting microdeletion or/and microduplication of congenital heart disease
CN112639127A (en) Method for detecting and quantifying genetic alterations
TW201300528A (en) Method for hla-dqb1 genotyping and related primers thereof
CN115216539A (en) Maternal cell pollution detection kit and application thereof
CN114134212A (en) Primer probe combination and kit for plasmid quantification
CN115125295A (en) Genotyping standard substance for multi-site sustainable use
CN108841931B (en) Primer group and detection kit for detecting STR locus of human chromosome 4 and application of primer group and detection kit
CN117925828B (en) System and method for determining that SMN gene mutation is located on SMN1 gene or SMN2 gene
WO2022126750A1 (en) Method for detecting presence or proportion of donor in receptor sample, and kit
KR102543976B1 (en) HLA-B genotype analysis method using Korean-specific SNPs and optimized pipeline
KR102511161B1 (en) HLA-A genotype analysis method using Korean-specific SNPs and optimized pipeline
CN117904286B (en) System and method for determining that SMN gene mutation is located in SMN1 gene

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16900263

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 16900263

Country of ref document: EP

Kind code of ref document: A1